Dambkowski Carl sold ORKA
May 21, 2026 · Form 4 insider transaction
Dambkowski Carl sold 13,235 shares of Oruka Therapeutics, Inc. at $59.97 per share, a transaction worth $793.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
13,235
Price
$59.97
Total value
$793.7K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 21, 2026
Filing dateMay 22, 2026
Shares owned after73,743
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 19, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.71 to $60.31, inclusive.